DK1154785T3 - Inhibitorer for hæmostase og immunfunktion - Google Patents
Inhibitorer for hæmostase og immunfunktionInfo
- Publication number
- DK1154785T3 DK1154785T3 DK00907310T DK00907310T DK1154785T3 DK 1154785 T3 DK1154785 T3 DK 1154785T3 DK 00907310 T DK00907310 T DK 00907310T DK 00907310 T DK00907310 T DK 00907310T DK 1154785 T3 DK1154785 T3 DK 1154785T3
- Authority
- DK
- Denmark
- Prior art keywords
- hemostasis
- inhibitors
- immune function
- related protein
- complement related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25360499A | 1999-02-19 | 1999-02-19 | |
US44479499A | 1999-11-22 | 1999-11-22 | |
PCT/US2000/004161 WO2000048625A2 (en) | 1999-02-19 | 2000-02-17 | Inhibitors for use in hemostasis and immune function |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1154785T3 true DK1154785T3 (da) | 2003-11-17 |
Family
ID=26943406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00907310T DK1154785T3 (da) | 1999-02-19 | 2000-02-17 | Inhibitorer for hæmostase og immunfunktion |
Country Status (20)
Country | Link |
---|---|
US (1) | US6448221B1 (da) |
EP (2) | EP1154785B1 (da) |
JP (1) | JP2002537270A (da) |
KR (1) | KR20010102130A (da) |
CN (1) | CN1341027A (da) |
AT (1) | ATE245439T1 (da) |
AU (1) | AU772103B2 (da) |
BR (1) | BR0008298A (da) |
CA (1) | CA2361273A1 (da) |
CZ (1) | CZ20012916A3 (da) |
DE (1) | DE60004015T2 (da) |
DK (1) | DK1154785T3 (da) |
ES (1) | ES2202061T3 (da) |
HK (1) | HK1039892A1 (da) |
HU (1) | HUP0105284A3 (da) |
IL (1) | IL144460A0 (da) |
NO (1) | NO20014012L (da) |
PL (1) | PL349924A1 (da) |
PT (1) | PT1154785E (da) |
WO (1) | WO2000048625A2 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6525174B1 (en) | 1997-06-06 | 2003-02-25 | Human Genome Sciences, Inc. | Precerebellin-like protein |
US20040014650A1 (en) * | 2002-07-17 | 2004-01-22 | Sheppard Paul D | Methods for enhancing wound repair |
US6544946B1 (en) * | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
MY128992A (en) * | 2000-08-25 | 2007-03-30 | Merck Patent Gmbh | Saratin for inhibiting platelet adhesion to collagen |
DE60124285T3 (de) | 2000-09-29 | 2011-03-17 | Cordis Corp., Miami Lakes | Beschichtete medizinische geräte |
CA2478675A1 (en) * | 2002-03-08 | 2003-09-18 | Zymogenetics, Inc. | Inhibitors for use in hemostasis |
NO20035748D0 (no) * | 2003-12-19 | 2003-12-19 | Amersham Health As | Optisk avbildning av sårbar arteriosklerose |
US9471978B2 (en) | 2004-10-04 | 2016-10-18 | Banner Health | Methodologies linking patterns from multi-modality datasets |
WO2006104964A2 (en) * | 2005-03-28 | 2006-10-05 | University Of Louisville Research Foundation, Inc. | Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30 |
WO2007014798A2 (en) * | 2005-07-29 | 2007-02-08 | Laboratoires Serono S.A. | Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
WO2008075589A1 (ja) * | 2006-12-21 | 2008-06-26 | Chisso Corporation | 血小板凝集惹起物質 |
JP5747370B2 (ja) * | 2009-03-31 | 2015-07-15 | 国立大学法人浜松医科大学 | 高病原性口腔細菌の高感度検出法 |
WO2023215294A1 (en) * | 2022-05-02 | 2023-11-09 | The Board Of Trustees Of The Leland Stanford Junior University | Complement pathway inhibition for wound healing |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869330A (en) | 1995-06-05 | 1999-02-09 | Whitehead Institute For Biomedical Research | DNA encoding a novel serum protein produced exclusively in adipocytes |
EP1000084A4 (en) | 1997-07-08 | 2003-03-26 | Human Genome Sciences Inc | 123 PROTEIN SEPARATED BY HUMAN |
US6265544B1 (en) * | 1997-07-18 | 2001-07-24 | Zymogenetics, Inc. | Adipocyte-specific protein homologs |
PT1000149E (pt) | 1997-08-01 | 2007-08-03 | Serono Genetics Inst Sa | 5' ests para proteínas segregadas identificadas a partir de tecidos do cérebro. |
DE69834334T2 (de) | 1997-08-26 | 2007-04-26 | Zymogenetics, Inc., Seattle | Für adipozyten spezifische protein homologe |
DK1033134T3 (da) | 1997-10-29 | 2007-07-16 | Otsuka Pharma Co Ltd | Sammensætninger, som inhiberer proliferation af glat muskel, og fremgangsmåde til diagnosticering af arteriosklerose |
EP1037979A2 (en) | 1997-12-03 | 2000-09-27 | Genentech, Inc. | Polypeptides and nucleic acids encoding the same |
AU1929599A (en) | 1997-12-30 | 1999-07-19 | Chiron Corporation | Bone marrow secreted proteins and polynucleotides |
ID27813A (id) | 1998-01-28 | 2001-04-26 | Corixa Corp | Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya |
CA2327317A1 (en) | 1998-04-29 | 1999-11-04 | Genesis Research And Development Corporation Limited | Polynucleotides isolated from skin cells and methods for their use |
EP1085897A4 (en) | 1998-05-21 | 2003-03-12 | Smithkline Beecham Corp | ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT) |
-
2000
- 2000-02-17 IL IL14446000A patent/IL144460A0/xx unknown
- 2000-02-17 AT AT00907310T patent/ATE245439T1/de not_active IP Right Cessation
- 2000-02-17 BR BR0008298-8A patent/BR0008298A/pt not_active IP Right Cessation
- 2000-02-17 WO PCT/US2000/004161 patent/WO2000048625A2/en not_active Application Discontinuation
- 2000-02-17 CA CA002361273A patent/CA2361273A1/en not_active Abandoned
- 2000-02-17 KR KR1020017010308A patent/KR20010102130A/ko not_active Application Discontinuation
- 2000-02-17 PL PL00349924A patent/PL349924A1/xx not_active Application Discontinuation
- 2000-02-17 EP EP00907310A patent/EP1154785B1/en not_active Expired - Lifetime
- 2000-02-17 ES ES00907310T patent/ES2202061T3/es not_active Expired - Lifetime
- 2000-02-17 HU HU0105284A patent/HUP0105284A3/hu unknown
- 2000-02-17 PT PT00907310T patent/PT1154785E/pt unknown
- 2000-02-17 DK DK00907310T patent/DK1154785T3/da active
- 2000-02-17 DE DE60004015T patent/DE60004015T2/de not_active Expired - Fee Related
- 2000-02-17 US US09/506,855 patent/US6448221B1/en not_active Expired - Fee Related
- 2000-02-17 CN CN00803958A patent/CN1341027A/zh active Pending
- 2000-02-17 JP JP2000599415A patent/JP2002537270A/ja active Pending
- 2000-02-17 AU AU28832/00A patent/AU772103B2/en not_active Ceased
- 2000-02-17 EP EP03008817A patent/EP1382345A3/en not_active Withdrawn
- 2000-02-17 CZ CZ20012916A patent/CZ20012916A3/cs unknown
-
2001
- 2001-08-17 NO NO20014012A patent/NO20014012L/no unknown
-
2002
- 2002-02-15 HK HK02101086.1A patent/HK1039892A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20012916A3 (cs) | 2002-05-15 |
WO2000048625A3 (en) | 2000-12-28 |
ES2202061T3 (es) | 2004-04-01 |
EP1154785A2 (en) | 2001-11-21 |
EP1154785B1 (en) | 2003-07-23 |
AU772103B2 (en) | 2004-04-08 |
BR0008298A (pt) | 2002-02-19 |
DE60004015D1 (de) | 2003-08-28 |
PL349924A1 (en) | 2002-10-21 |
HUP0105284A3 (en) | 2003-12-29 |
US6448221B1 (en) | 2002-09-10 |
KR20010102130A (ko) | 2001-11-15 |
AU2883200A (en) | 2000-09-04 |
EP1382345A2 (en) | 2004-01-21 |
ATE245439T1 (de) | 2003-08-15 |
JP2002537270A (ja) | 2002-11-05 |
DE60004015T2 (de) | 2004-04-15 |
CN1341027A (zh) | 2002-03-20 |
IL144460A0 (en) | 2002-05-23 |
HK1039892A1 (zh) | 2002-05-17 |
HUP0105284A2 (hu) | 2002-05-29 |
NO20014012D0 (no) | 2001-08-17 |
CA2361273A1 (en) | 2000-08-24 |
WO2000048625A2 (en) | 2000-08-24 |
NO20014012L (no) | 2001-10-02 |
EP1382345A3 (en) | 2004-01-28 |
PT1154785E (pt) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1154785T3 (da) | Inhibitorer for hæmostase og immunfunktion | |
DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
DK1311542T3 (da) | Tolerogene peptider | |
NZ263344A (en) | Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use | |
NO990279L (no) | Isobutylgaba og dets derivater for behandling av smerte | |
IL161591A0 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
DE69703689D1 (de) | Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia | |
FI883487A0 (fi) | Ihmisen kudostekijäinhibiittorin DNA-klooni | |
IS5591A (is) | Grunnmassaprótínsamsetningar til sáragræðslu | |
DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
DK0643585T3 (da) | Anvendelsen af lipoprotein-associeret koagulationsinhibitor (LACI) til fremstilling af et lægemiddel til behandlingen af ak | |
GB9930768D0 (en) | Composition | |
EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака | |
NO20021410D0 (no) | Forebygging og behandling av blodkoagulasjons-relaterte sykdommer | |
ATE312179T1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
DE60011601D1 (de) | Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen | |
DE69737088D1 (de) | Therapeutisches agens zur behandlung von fiv infektionen | |
ATE222501T1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
DE50207168D1 (de) | Kombinationspräparat zur Therapie von immunologischen Erkrankungen | |
DE60139574D1 (de) | Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung | |
GEP19991605B (en) | Inhibitor, Its Obtaining and Use | |
RU94025749A (ru) | Способ оперативного лечения дуоденостаза | |
UA37445A (uk) | Протизапальний засіб |